DadFinStart your free week
DadFin › Stocks › Healthcare › IDXX

IDEXX Laboratories, Inc. (IDXX) stock score

Healthcare · Diagnostics & Research · United States

$518.00 ▲ +0.95% today

90.1
Dad Score, out of 100
strong

IDEXX Laboratories, Inc. (IDXX) is a Diagnostics & Research company in the Healthcare sector, listed in the United States. On DadFin's weekly run it scores 90.1 out of 100 on the Dad Score, a strong reading that places the business ahead of 90% of the 5,774 US and Canadian stocks DadFin fully scores. Inside Healthcare it ranks #90 of 974. Its strongest axes are quality, growth and price action; its weakest are valuation and conviction.

Scores from the run of Oct 4, 2026. The Dad Score answers one question: how good is this business, measured against its own sector. How it is built →

The eight axes

Valuation
Below average
Quality
Strong
Growth
Above average
Price action
Strong
Risk
Strong
Conviction
Below average
Liquidity
Strong
Macro
Above average

Each axis is ranked inside the stock's own sector. Subscribers see the percentile and every input behind each bar.

Key numbers

P/E (trailing)36.4×
P/E (forward)31.0×
Dividend yield0.00%
Return on capital61.9%
Operating margin35.0%
Revenue growth (YoY)+10.4%
FCF yield2.5%
Net debt / EBITDA0.55×
Piotroski F-Score8 / 9
52-week change-17.4%
Market cap$40.9B
Next earningsNov 2, 2026

What subscribers see on IDXX

Start your free weekSubscriber? Open the full research →

Diagnostics & Research peers

StockCompanyDad ScoreBandMarket cap
TMOThermo Fisher Scientific Inc.77.0good$242.1B
DHRDanaher Corporation79.6good$150.5B
NTRANatera, Inc.86.1strong$59.1B
AAgilent Technologies, Inc.79.9good$47.3B
IQVIQVIA Holdings Inc.82.3good$42.5B
WATWaters Corporation78.8good$41.7B
ILMNIllumina, Inc.35.1weak$41.2B
MTDMettler-Toledo International Inc.63.2middling$29.8B

Prices from DadFin's live feed (refreshed about every 15 minutes in the session); scores from the weekly run of Oct 4, 2026. Fundamentals as reported in the latest filings. Research, not investment advice.